These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 3256857)
41. Measles and the government. Smith T Br Med J (Clin Res Ed); 1987 Apr; 294(6578):989-90. PubMed ID: 3119014 [No Abstract] [Full Text] [Related]
42. Measles, mumps, and rubella vaccine coverage in 2 year old children in East Lancashire--better than it looks. Clark A; Marshall R Commun Dis Public Health; 1999 Jan; 2(1):50-3. PubMed ID: 10462897 [TBL] [Abstract][Full Text] [Related]
43. Rubella prevention--a new era? Hutchinson A J R Coll Gen Pract; 1988 May; 38(310):193-4. PubMed ID: 3210177 [No Abstract] [Full Text] [Related]
44. [Vaccination against mumps successful]. Rümke HC; Plantinga AD; Conyn-Van Spaendonck MA Ned Tijdschr Geneeskd; 1993 Oct; 137(41):2109-10. PubMed ID: 8413739 [No Abstract] [Full Text] [Related]
45. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96]. Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798 [TBL] [Abstract][Full Text] [Related]
46. [Epidemiologic study of measles, rubella and mumps with regard to the possibility of their control by immunization]. Rodríguez Borrego MJ; García León J; Bolumar F; Nájera E Rev Sanid Hig Publica (Madr); 1985; 59(1-2):117-25. PubMed ID: 4059834 [No Abstract] [Full Text] [Related]
47. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251 [TBL] [Abstract][Full Text] [Related]
48. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps. Smorodintsev AA; Nasibov MN; Jakovleva NV Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140 [TBL] [Abstract][Full Text] [Related]
49. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation]. Zverev VV; Iuminova NV Vopr Virusol; 2004; 49(3):8-11. PubMed ID: 15188648 [TBL] [Abstract][Full Text] [Related]
50. [Vaccination against mumps successful]. De Jong GD Ned Tijdschr Geneeskd; 1993 Oct; 137(41):2110. PubMed ID: 8413740 [No Abstract] [Full Text] [Related]
51. Prevalence of hepatitis B markers and measles, mumps, and rubella antibodies among Jewish refugees from the former Soviet Union. Hurie MB; Gennis MA; Hernandez LV; Dindzans VJ; Davis JP JAMA; 1995 Mar 22-29; 273(12):954-6. PubMed ID: 7884955 [TBL] [Abstract][Full Text] [Related]
52. Mumps vaccination. Hilleman MR Mod Trends Med Virol; 1970; 2(0):241-61. PubMed ID: 5527958 [No Abstract] [Full Text] [Related]
55. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic. Ehrenkranz NJ; Ventura AK; Medler EM; Jackson JE; Kenny MT Bull World Health Organ; 1975; 52(1):81-5. PubMed ID: 764997 [TBL] [Abstract][Full Text] [Related]
56. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella]. Just M; Berger R; Glück R; Wegmann A Schweiz Med Wochenschr; 1985 Nov; 115(48):1727-30. PubMed ID: 4081704 [TBL] [Abstract][Full Text] [Related]
57. [Rubella, measles, mumps--epidemiologic, occupational medicine significance and efficacy of adult vaccination]. Hofmann F; Sydow B Offentl Gesundheitswes; 1989 Jun; 51(6):299-302. PubMed ID: 2526940 [TBL] [Abstract][Full Text] [Related]
58. Measles, mumps, and rubella vaccines. Wharton M; Cochi SL; Williams WW Infect Dis Clin North Am; 1990 Mar; 4(1):47-73. PubMed ID: 2407778 [TBL] [Abstract][Full Text] [Related]